New Fibrosis clinical trials: 172 posted since Nov 2024

Name: New Fibrosis clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Fibrosis clinical trials: 172 rows for $8.60, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 8 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, enrollment type, location countries and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/fibrosis, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 5, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

172 clinical studies in fibrosis were first posted on ClinicalTrials.gov from November 12, 2024 to November 5, 2026; 19 have an industry sponsor and 127 are recruiting or about to. The newest, NCT07918378, was posted on November 5, 2026: Treatment Outcomes and Predictors After Endovascular Intervention for Portal Hypertension-Related... (University Medical Center Ho Chi Minh City (UMC)).

The request: Every new Fibrosis clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

172New trials
19Industry sponsored
127Recruiting or not yet
November 5, 2026Latest posted

Newest trials

The newest 100 of 172, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 5, 2026	NCT07918378	Treatment Outcomes and Predictors After Endovascular Intervention for Portal Hypertension-Related Gastrointestinal Bleeding in Cirrhosis	University Medical Center Ho Chi Minh City (UMC)	Observational	Recruiting	Cirrhosis, Portal Hypertension Related to Cirrhosis, GI Bleeding, Gastrointestinal Bleeding	167	Vietnam	clinicaltrials.gov
October 22, 2026	NCT07889726	"Anticipant"-TIPS After a First Portal-hypertension-related Complication in Cirrhosis	University Hospital, Toulouse	Not applicable	Not yet recruiting	Cirrhosis	266	France	clinicaltrials.gov
October 15, 2026	NCT07876648	Prospective Trial of [18F]AlF-FAPI-74 for PET Imaging of Fibroblast Activation Protein in Patients With Endometriosis	Universitaire Ziekenhuizen KU Leuven	Not applicable	Recruiting	Endometriosis, Deep Infiltrating Endometriosis, Women, Superficial Peritoneal Endometriosis, Fibrosis	64	Belgium	clinicaltrials.gov
October 13, 2026	NCT07870850	Clinical Outcomes in Patients Presenting With Acute Variceal Bleeding	Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor	Observational	Completed	Portal Hypertension Related to Cirrhosis, Variceal Bleeding, Cirrhoses, Liver	149	Romania	clinicaltrials.gov
October 9, 2026	NCT07867574	AGED Diagnostics Clinical Validation Study	Active Genomes Expressed Diagnostics, Corp	Observational	Not yet recruiting	MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASLD (Metabolic Dysfunction-Associated Steatotic Liver...	500	United States	clinicaltrials.gov
October 6, 2026	NCT07860814	Ultrasound Biomarkers for Assessing Eligibility and Response to Resmetirom Therapy	Radnet Management, Inc.	Observational	Not yet recruiting	Metabolic Dysfunction-steatohepatitis (MASH)	524	United States	clinicaltrials.gov
October 2, 2026	NCT07855913	EUS-Guided Coil and Glue vs Glue Injection for Bleeding Gastric Varices in Cirrhosis	Medanta, The Medicity, India	Not applicable	Recruiting	Gastric Varices Bleeding, Cirrhosis	110	India, United States	clinicaltrials.gov
October 1, 2026	NCT07851324	Stromal Desmoplastic Reaction as a Predictive Factor for Lymph Node Metastasis in Medullary Thyroid Cancer	Aristotle University Of Thessaloniki	Observational	Not yet recruiting	Medullary Thyroid Carcinoma	74		clinicaltrials.gov
September 15, 2026	NCT07820995	Mechanistic Evaluation of Atrasentan in Patients With IgA Nephropathy (IgAN)	University of Illinois Chicago	Phase 4	Not yet recruiting	IgA Nephropathy (IgAN), Immunoglobulin A Nephropathy (IgAN)	20	United States	clinicaltrials.gov
September 15, 2026	NCT07820917	Chronic Pain Optimization and Management for Relief and Functionality With TEA in Cirrhosis	University of Michigan	Not applicable	Not yet recruiting	Cirrhosis	100	United States	clinicaltrials.gov
September 11, 2026	NCT07816185	A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)	Pulmovant, Inc.	Phase 3	Recruiting	Pulmonary Hypertension, Interstitial Lung Disease, Vascular Diseases, Cardiovascular Diseases, Fibrosis	376	United States	clinicaltrials.gov
September 10, 2026	NCT07811713	Effect of LSD on Renal Function in Cirrhotic Patients With Portal Hypertension	Northern Jiangsu People's Hospital	Observational	Completed	Cirrhosis, Liver, Splenectomy; Status, Renal Function Abnormal, Portal Hypertension	496		clinicaltrials.gov
September 10, 2026	NCT07811700	Effect of LSD on Lipid Profiles Within 1 Year Postoperatively in Cirrhosis Patients With Portal Hypertension Bleeding	Northern Jiangsu People's Hospital	Observational	Completed	Lipid Profiles, Cirrhosis, Liver, Portal Hypertension, Splenectomy; Status	150	China	clinicaltrials.gov
September 9, 2026	NCT07810855	Using Bedside Ultrasound to Understand Fluid Management in Patients With Chronic Liver Disease	Royal Free Hospital NHS Foundation Trust	Observational	Not yet recruiting	Cirrhosis, Ascites Hepatic, Fluid Balance	100		clinicaltrials.gov
September 9, 2026	NCT07808970	Prospective Stage-Stratified Histopathologic Study and Proposed Disease-Evolution Model of Gluteal Permanent Synthetic Filler Complications	Research Inc	Observational	Not yet recruiting	Foreign-Body Reaction, Granulomatous Disease, Soft Tissue Necrosis Lower Limb, Gluteal Permanent Synthetic Filler...	200	Colombia	clinicaltrials.gov
September 2, 2026	NCT07800598	Role of Allopurinol in Prevention of Complications Related to Decompensated Cirrhosis of Liver	Bangladesh Medical University	Phase 4	Recruiting	Cirrhoses, Liver, Decompensated Cirrhosis of Liver	54	Bangladesh	clinicaltrials.gov
September 1, 2026	NCT07797114	Predictors of Mortality in Cirrhotic Patients With Acute Kidney Injury	Assiut University	Observational	Not yet recruiting	AKI in Cirrhosis	100		clinicaltrials.gov
September 1, 2026	NCT07797101	Body-weight Reduction Effect on Portal Hypertension in Compensated Cirrhosis	The Second Affiliated Hospital of Chongqing Medical University	Not applicable	Not yet recruiting	Cirrhosis, Portal Hypertension, Fatty Liver Disease, GLP-1	50		clinicaltrials.gov
August 31, 2026	NCT07795476	Artificial Intelligence For Outcomes Research in Crohn's Disease: Digital Pathology Assessment of Fibrosis and Association With Patient...	PharmaNest, Inc	Observational	Not yet recruiting	Crohn Disease, Fibrostenotic Crohn's Disease, CD - Crohn's Disease	100	Spain	clinicaltrials.gov
August 28, 2026	NCT07792850	The Application of Lifestyle Enhancing Validated Integrative Therapies for Everyday Pain in Cirrhosis	University of Pennsylvania	Not applicable	Not yet recruiting	Cirrhoses, Liver	625	United States	clinicaltrials.gov
August 20, 2026	NCT07777705	Application of Different Scores in Predicting Outcomes of Cirrhotic Patients Awaiting Liver Transplantation	Assiut University	Observational	Not yet recruiting	Liver Cirrhosis, Liver Transplant	153		clinicaltrials.gov
August 20, 2026	NCT07775638	Detecting Liver Fibrosis in Patients At-risk	Helse Stavanger HF	Observational	Not yet recruiting	Fatty Liver, NAFLD - Non-Alcoholic Fatty Liver Disease, Nash, MASLD (Metabolic Dysfunction-Associated Steatotic Liver...	1,200	Norway	clinicaltrials.gov
August 13, 2026	NCT07763015	Study of Resmetirom in Children and Adolescents With MASH	Madrigal Pharmaceuticals, Inc.	Phase 2	Recruiting	MASH, MASH - Metabolic Dysfunction-Associated Steatohepatitis	61	United States	clinicaltrials.gov
August 6, 2026	NCT07750587	Predicting Response and Exposure Changes in Cirrhosis for Effectiveness	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	Not applicable	Not yet recruiting	Liver Cirrhosis	45		clinicaltrials.gov
July 30, 2026	NCT07737444	Association of Lipoprotein(a) With Postoperative Atrial Fibrillation	Anthony Tang	Observational	Not yet recruiting	POAF, Atrial Fibrillation (AF)	20		clinicaltrials.gov
July 20, 2026	NCT07715500	Magnetic Resonance Cholangiopancreatography in Living Liver Donors and Its Relationship With Post Operative Recipient Biliary Complications	Institute of Liver and Biliary Sciences, India	Not applicable	Recruiting	Chronic Liver Disease and Cirrhosis, Liver Transplant; Complications, Donor Hepatectomy	100	India	clinicaltrials.gov
July 17, 2026	NCT07712679	Evaluation of Kidney Fibrosis Via FAPI PET/CT	Medical University of Vienna	Not applicable	Recruiting	Chronic Kidney Disease	30	Austria	clinicaltrials.gov
July 15, 2026	NCT07704892	A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to...	GlaxoSmithKline	Phase 3	Recruiting	Metabolic Dysfunction-associated Steatohepatitis	380	Japan, United States	clinicaltrials.gov
July 14, 2026	NCT07703540	Inferior Vena Cava Pressure as Alternative to Hepatic Venous Pressure for EUS-guided Portal Pressure Gradient Measurement	University Hospital Muenster	Observational	Completed	Cirrhosis, Liver Disease Chronic, Portal Hypertension	40	Germany	clinicaltrials.gov
July 14, 2026	NCT07701993	A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With...	GlaxoSmithKline	Phase 3	Recruiting	Metabolic Dysfunction-associated Steatohepatitis	1,740	Japan, United States	clinicaltrials.gov
July 6, 2026	NCT07685353	Influence of Donor and Recipient Genetic Polymorphisms on Graft Steatosis After Liver Transplant	Institute of Liver and Biliary Sciences, India	Observational	Recruiting	Chronic Liver Disease and Cirrhosis	50	India	clinicaltrials.gov
July 1, 2026	NCT07679893	Phase 2 Clinical Trial of MNKD-201 (Nintedanib Dry Powder Inhalation) in Patients With Idiopathic Pulmonary Fibrosis	Mannkind Corporation	Phase 2	Recruiting	Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF)	153	Canada	clinicaltrials.gov
June 25, 2026	NCT07668778	Evaluation of a Modified Bowel Preparation Regimen in Cirrhotic Patients Undergoing Colonoscopy	Hospital do Divino Espírito Santo de Ponta Delgada	Phase 3	Not yet recruiting	Cirrhosis, Bowel Preparation	252	Portugal	clinicaltrials.gov
June 25, 2026	NCT07667608	Ultrasound Assessment of Diaphragmatic Structure and Function in Patients With Liver Cirrhosis: A Point-of-Care Tool for Predicting...	Assiut University	Observational	Not yet recruiting	Cirrhosis of the Liver, Ascites, Pleural Effusion Disorder, Hepatocellular Carcinoma (HCC), Sarcopenia, Diaphragm...	120		clinicaltrials.gov
June 18, 2026	NCT07658222	Prospective Investigation of Cirrhotic Cardiomyopathy in Humans	Vanderbilt University Medical Center	Observational	Recruiting	Cirrhotic Cardiomyopathy	440	United States	clinicaltrials.gov
June 16, 2026	NCT07652203	Impact of Propranolol on the Prognosis of Patients With Decompensated Cirrhosis and MELD Score > 9	General Hospital of Shenyang Military Region	Not applicable	Not yet recruiting	Cirrhosis	466	China	clinicaltrials.gov
June 16, 2026	NCT07652151	UNMASK: Unveiling the Pathobiology of Metabolic Dysfunction-Associated Steatotic Liver Disease for the Discovery of Novel Therapeutics and...	Fundación Pública Andaluza para la gestión de la Investigación en Sevilla	Not applicable	Recruiting	MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)	450	Italy, Spain, Turkey (Türkiye)	clinicaltrials.gov
June 16, 2026	NCT07651683	Clinical Characteristics of Recompensation	Third Affiliated Hospital, Sun Yat-Sen University	Observational	Active not recruiting	Cirrhosis, Alcohol Related Liver Disease, HBV (Hepatitis B Virus), Recompensation	300	China	clinicaltrials.gov
June 15, 2026	NCT07647978	Development of a Predictive Score for the Risk of Infection in the Immediate Post-liver-transplant Period	Hospices Civils de Lyon	Observational	Not yet recruiting	Cirrhosis, Acute Hepatitis, Liver, mHLA-DR	279	France	clinicaltrials.gov
June 11, 2026	NCT07642297	TL1A Inhibition in Systemic Sclerosis-Related Skin Fibrosis and Immunological Alterations: A Proof-of-Concept In Vitro Study (FIBROSTOP)	Fondazione Policlinico Universitario Campus Bio-Medico	Observational	Not yet recruiting	Systemic Sclerosis (SSc), Diffuse Cutaneous Systemic Sclerosis, Skin Fibrosis	20	Italy	clinicaltrials.gov
June 8, 2026	NCT07634237	Personalized Nutritional Intervention in Patients Undergoing TIPS Insertion for Refractory Ascites to Prevent Overt Hepatic Encephalopathy	McGill University Health Centre/Research Institute of the McGill University Health Centre	Not applicable	Not yet recruiting	Cirrhosis, Refractory Ascites, TIPS Insertion	50	Canada	clinicaltrials.gov
June 8, 2026	NCT07631637	Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)	Regeneron Pharmaceuticals	Phase 2	Recruiting	Metabolic Dysfunction-Associated Steatohepatitis, MASH	360	Puerto Rico, United Kingdom, United States	clinicaltrials.gov
June 1, 2026	NCT07616466	Prophylactic Antibiotics in the Endoscopic Secondary Prevention of Cirrhotic Patients With Varices: a Retrospective Study	Second Affiliated Hospital, Zhejiang University, School of Medicine	Observational	Completed	Cirrhosis, Liver Hypertension, Portal Variceal Hemorrhage	480	China	clinicaltrials.gov
May 22, 2026	NCT07604272	Reversing InGuinal Hernia Trial: The Evaluation of Sex Hormones to Reverse Inguinal Hernias in Males	Northwestern University	Phase 1	Recruiting	Inguinal Hernia Unilateral, Inguinal Hernia Bilateral, Inguinal Hernia Without Obstruction or Gangrene, Inguinal...	30	United States	clinicaltrials.gov
May 14, 2026	NCT07588373	Effect of Laparoscopic Splenectomy on Lipid Profiles in Cirrhotic Patients With Hypersplenism (2-Year Follow-Up)	Northern Jiangsu People's Hospital	Observational	Not yet recruiting	Cirrhosis, Splenectomy; Status, Hypersplenism, Lipid Profiles	30	China	clinicaltrials.gov
May 14, 2026	NCT07588334	Effect of LSD on Lipid Profiles in Cirrhosis Patients With Portal Hypertension Bleeding (2-Year Follow-Up)	Northern Jiangsu People's Hospital	Observational	Not yet recruiting	Cirrhosis, Liver, Splenectomy; Status, Portal Hypertension, Lipid Profiles	30	China	clinicaltrials.gov
May 14, 2026	NCT07587671	Underdilated VCX-TIPS Versus EVL Plus NSBB for Secondary Prophylaxis of Variceal Bleeding in Cirrhosis	West China Hospital	Not applicable	Not yet recruiting	Liver Cirrhosis, Portal Hypertension, Gastroesophageal Varices Bleeding, Esophageal Varices, Hepatic Encephalopathy	240	China	clinicaltrials.gov
May 14, 2026	NCT07585786	Effect of LSD on Renal Function in Cirrhosis Patients With Portal Hypertension Bleeding (2-Year Follow-Up)	Northern Jiangsu People's Hospital	Observational	Not yet recruiting	Cirrhosis, Liver, Splenectomy; Status, Renal Function Abnormal, Portal Hypertension	30		clinicaltrials.gov
May 14, 2026	NCT07585773	Effect of Laparoscopic Splenectomy on Renal Function in Cirrhotic Patients With Hypersplenism (2-Year Follow-Up)	Northern Jiangsu People's Hospital	Observational	Not yet recruiting	Cirrhosis, Splenectomy; Status, Hypersplenism, Kidney Function Issue	30	China	clinicaltrials.gov
May 5, 2026	NCT07568275	Comparison of Angiotensin II to Standard Dose Vasopressors on Change in Arterial Elastance	The Cleveland Clinic	Early phase 1	Active not recruiting	Septic Shock, Cirrhosis, Vasodilatory Shock, Acute Kidney Injury	30	United States	clinicaltrials.gov
May 4, 2026	NCT07565337	The Application of Biomarkers in the Care of Patients With Atrial Fibrillation	National Taiwan University Hospital	Observational	Withdrawn	Atrial Fibrillation, Biomarker	0	Taiwan	clinicaltrials.gov
April 28, 2026	NCT07554183	4D-Flow MRI Assessment of Portal Hypertension and TIPS Outcomes in Cirrhosis	Assistance Publique - Hôpitaux de Paris	Not applicable	Recruiting	Cirrhosis, Portal Hypertension	60	France	clinicaltrials.gov
April 27, 2026	NCT07552870	Intravenous Ciprofloxacin Versus Intravenous Ceftriaxone: Spontaneous Bacterial Peritonitis in Cirrhosis of Liver	Shahida Islam Medical Complex	Not applicable	Completed	Cirrhosis	310	Pakistan	clinicaltrials.gov
April 16, 2026	NCT07533565	A Pilot Study of Mirabegron and Montelukast in Cirrhotic Patients	Kafrelsheikh University	Phase 4	Completed	Cirrhosis, Asthma	78	Egypt	clinicaltrials.gov
April 14, 2026	NCT07529262	Can Aspirin Reduce the Risk of HCC in Cirrhosis: The AspiRe HCC Trial	Curtin University	Phase 3	Not yet recruiting	Liver Cirrhosis	890		clinicaltrials.gov
April 14, 2026	NCT07528690	Microbiota trAnSplant ThERaPy In hEpatiC Encephalopathy (MASTERPIECE)	VA Office of Research and Development	Phase 2	Not yet recruiting	Hepatic Encephalopathy, Cirrhosis	162	United States	clinicaltrials.gov
April 9, 2026	NCT07521332	Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis	Asian Institute Of Medical Sciences	Phase 4	Recruiting	Cirrhosis, Esophageal and Gastric Varices, Ascites, Hepatic Encephalopathy, Portal Vein Thrombosis, Portal Hypertension	220	Pakistan	clinicaltrials.gov
April 2, 2026	NCT07506642	Patient Reported Outcomes In Liver Biopsy (EUS vs. Percutaneous)	University Hospital Muenster	Observational	Completed	Chronic Liver Disease (CLD), Liver Transplantation, Cirrhosis	102	Germany	clinicaltrials.gov
March 19, 2026	NCT07481877	Portosystemic Shunt-associated Pulmonary Hypertension Multi-center Prospective Cohort Study	Chinese Pulmonary Vascular Disease Research Group	Observational	Not yet recruiting	Portosystemic Shunt, Pulmonary Hypertension	300		clinicaltrials.gov
March 19, 2026	NCT07481734	Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)	Hudson Biotech	Phase 2	Recruiting	Metabolic Associated Steatotic Liver Disease, Nonalcoholic Steatohepatitis, Hepatic Steatosis	120	China	clinicaltrials.gov
March 18, 2026	NCT07480096	Efficacy and Safety of Lemborexant for Patients With Cirrhosis and Sleep Problems	Universitas Indonesia	Phase 2	Completed	Cirrhosis, Liver Cirrhosis, Sleep Quality, Insomnia, Hepatic Encephalopathy	82	Indonesia	clinicaltrials.gov
March 16, 2026	NCT07473375	Indicators Affecting PVT Recanalization	Shanghai Zhongshan Hospital	Observational	Recruiting	Portal Vein Thrombosis, Cirrhosis, Portal Hypertension Related to Cirrhosis, Portal Hypertension, Noncirrhotic	1,500	China	clinicaltrials.gov
March 13, 2026	NCT07471542	Copper Supplementation in Cirrhosis	University of Washington	Not applicable	Recruiting	Cirrhosis, Chronic Liver Disease, Fibrosis, Infection	30	United States	clinicaltrials.gov
March 13, 2026	NCT07469319	Biannual Screening for HCC Offered to Patients With Cirrhosis. Introducing Surveillance for Hepatocellular Carcinoma (HCC) in the Central...	University of Aarhus	Not applicable	Recruiting	Hepatocellular Carcinoma (HCC), Cirrhosis	617	Denmark	clinicaltrials.gov
March 11, 2026	NCT07465003	Cohort Study of Chronic Liver Disease Complicated by Sepsis	The Second Affiliated Hospital of Chongqing Medical University	Observational	Not yet recruiting	Cirrhosis, Sepsis	1,600		clinicaltrials.gov
March 10, 2026	NCT07462091	Vagus Nerve-guided Laparoscopic Splenectomy and Azygoportal Disconnection	Northern Jiangsu People's Hospital	Not applicable	Recruiting	Cirrhosis, Hypersplenism, Hypertension, Portal	15	China	clinicaltrials.gov
March 10, 2026	NCT07461545	Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS	Northern Jiangsu People's Hospital	Not applicable	Recruiting	Cirrhosis, Splenectomy, Portal Vein Thrombosis, Hypertension, Portal	20	China	clinicaltrials.gov
March 10, 2026	NCT07461532	Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD	Northern Jiangsu People's Hospital	Not applicable	Recruiting	Cirrhosis, Splenectomy, Portal Vein Thrombosis, Hypertension, Portal	20	China	clinicaltrials.gov
March 6, 2026	NCT07455175	Observational Clinical Study on the Association Between Lactate-mediated Gut Microbiota Alterations and Disease Progression in Liver...	Zhujiang Hospital	Observational	Not yet recruiting	Cirrhosis	200	China	clinicaltrials.gov
March 4, 2026	NCT07450144	A Large Language Model-based Chatbot for Alcohol Reduction in Patients With Steatotic Liver Disease	The University of Hong Kong	Not applicable	Recruiting	Steatotic Liver Disease	50	Hong Kong	clinicaltrials.gov
February 27, 2026	NCT07438288	Predictors of Decompensation, Acute-on-chronic Liver Failure and Mortality in Liver Cirrhosis	Singapore General Hospital	Observational	Recruiting	Cirrhosis and Chronic Liver Disease	2,200	Singapore	clinicaltrials.gov
February 27, 2026	NCT07437638	Clinical Efficacy and Survival Prediction Analysis of Transjugular Intrahepatic Portosystemic Shunt in Patients With Liver Cirrhosis	The Second Affiliated Hospital of Chongqing Medical University	Observational	Active not recruiting	Liver Cirrhosis, Hepatic Encephalopathy, TIPS	624	China	clinicaltrials.gov
February 20, 2026	NCT07424963	Hepatic Venous Pressure Gradient Versus Endoscopic Ultrasound-Guided Portal Pressure Gradient - Comparative Analysis (HEPCA)	Military University Hospital, Prague	Not applicable	Recruiting	Cirrhosis, Portal Hypertension, EUS, Non-Cirrhotic Portal Hypertension, HVPG, Hepatic Venous Pressure Gradient	40	Czechia	clinicaltrials.gov
February 18, 2026	NCT07417163	LiverSleep: A Behavioral Sleep Intervention for Patients With Cirrhosis and Insomnia	Massachusetts General Hospital	Not applicable	Completed	Cirrhosis, Insomnia	11	United States	clinicaltrials.gov
February 17, 2026	NCT07414095	Multidimensional Frailty Assessment and Post-Transplant Outcomes in Liver Transplant Candidates	Izmir Bakircay University	Observational	Recruiting	End-Stage Liver Disease, Liver Transplantation, Cirrhosis	60	Turkey (Türkiye)	clinicaltrials.gov
February 12, 2026	NCT07405944	Vericiguat and Reverse Remodeling Indices in Heart Failure	University Medical Centre Ljubljana	Phase 4	Recruiting	Heart Failure With Reduced Ejection Fraction (HFrEF), Chronic Heart Failure	70	Slovenia	clinicaltrials.gov
February 9, 2026	NCT07395141	Albumin in Acute Variceal Bleeding	King George's Medical University	Phase 3	Not yet recruiting	Acute Variceal Bleeding, Cirrhosis	60	India	clinicaltrials.gov
February 6, 2026	NCT07393074	PSYLIVER-PILOTE: Involvement of the Autonomic Nervous System in Hepatocellular Carcinoma (HCC)	Hospices Civils de Lyon	Not applicable	Recruiting	Hepato Cellular Carcinoma, Cirrhosis, Autonomic Nervous System, Central Nervous System	100	France	clinicaltrials.gov
February 5, 2026	NCT07390344	VIATORR® TIPS Study Evaluating 6-10mm Diameters (VIATIPS)	W.L.Gore & Associates	Observational	Recruiting	Ascites, Variceal Bleeding, Portal Hypertension Related to Cirrhosis	152	Italy, United States	clinicaltrials.gov
January 28, 2026	NCT07373769	Ultrasound Liver Imaging for Classification of Metabolic Dysfunction-associated Steatotic Liver Disease	University of British Columbia	Observational	Not yet recruiting	Metabolic Dysfunction-Associated Steatotic Liver Disease	145	Canada	clinicaltrials.gov
January 26, 2026	NCT07368309	Clinical Management Strategies for Patients With Cirrhosis and Esophagogastric Varices Complicated by Early-stage Upper Gastrointestinal...	Renmin Hospital of Wuhan University	Observational	Completed	Cirrhosis, Esophagogastric Varices, Early-stage Upper Gastrointestinal Cancer	206	China	clinicaltrials.gov
January 26, 2026	NCT07365709	Liver Cirrhosis Complicated by Clinically Significant Portal Hypertension	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Not applicable	Not yet recruiting	Portal Hypertension, Spleen Disease, Cirrhosis	107		clinicaltrials.gov
January 22, 2026	NCT07359742	Assessing Signatures for Fibrosis Detection in Chronic Liver Disease: A Step Beyond Conventional Biomarkers	Universitair Ziekenhuis Brussel	Not applicable	Recruiting	Chronic Liver Disease (CLD), Fibrosis of Liver	110	Belgium	clinicaltrials.gov
January 21, 2026	NCT07354789	The Feasibility, Safety, and Efficacy of EUS-Guided PSE: A Cohort Study	Qilu Hospital of Shandong University	Not applicable	Not yet recruiting	Cirrhosis, Portal Hypertension, Bleeding	50		clinicaltrials.gov
January 20, 2026	NCT07349654	Underdilated-stent Technique Improves Post-TIPS Encephalopathy	The Second Affiliated Hospital of Chongqing Medical University	Not applicable	Recruiting	Liver Cirrhosis, Variceal Bleeding, Cirrhosis, Ascites Hepatic, Hepatic Encephalopathy (HE)	72	China	clinicaltrials.gov
January 15, 2026	NCT07345052	Western Sweden Systemic Sclerosis Project	Sahlgrenska University Hospital	Observational	Recruiting	Scleroderma, Systemic, Fibrosis; Skin, Fibrosis Lung, Interstitial Lung Disease Due to Systemic Disease	150	Sweden	clinicaltrials.gov
January 13, 2026	NCT07335601	Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH	Madrigal Pharmaceuticals, Inc.	Phase 2	Recruiting	MASH - Metabolic Dysfunction-Associated Steatohepatitis	120	Canada, United States	clinicaltrials.gov
January 12, 2026	NCT07333183	A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD	Pulmovant, Inc.	Phase 2	Recruiting	Pulmonary Hypertension, Interstitial Lung Disease (ILD), Lung Diseases, Vascular Diseases, Cardiovascular Diseases...	20	United States	clinicaltrials.gov
January 8, 2026	NCT07325357	Effect of Pirfenidone on TA Fibrosis	Shanghai Zhongshan Hospital	Phase 4	Not yet recruiting	Takayasu Arteritis	92		clinicaltrials.gov
January 7, 2026	NCT07322237	DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis	Post Graduate Institute of Medical Education and Research, Chandigarh	Phase 4	Recruiting	Cirrhotic Cardiomyopathy, Empagliflozin, Cardiometabolic Risk Factors, Cirrhosis	400	India	clinicaltrials.gov
January 6, 2026	NCT07319299	STOP HCC-GAAD-APAC-Thailand	Mahidol University	Not applicable	Enrolling by invitation	Hepatecellular Carcinoma, Cirrhosis, HBV Infection	2,100	Thailand	clinicaltrials.gov
December 31, 2025	NCT07312136	MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study	Linkoeping University	Observational	Enrolling by invitation	MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, Cirrhosis, Advanced Fibrosis, Sarcopenia, Obesity &...	317	Sweden	clinicaltrials.gov
December 15, 2025	NCT07281846	TIPS With or Without BCAA	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Not applicable	Recruiting	BCAA, Cirrhosis, Portal Hypertension Related to Cirrhosis, Sarcopenia, Transjugular Intrahepatic Portosystemic Shunt	164	China	clinicaltrials.gov
December 12, 2025	NCT07280390	Microplastics, Cirrhosis and Portal Hypertension	Post Graduate Institute of Medical Education and Research, Chandigarh	Observational	Recruiting	Cirrhosis, Microplastics, Portal Hypertension Related to Cirrhosis, Nanoplastics, Pollution, Cirrhosis and Chronic...	30	India	clinicaltrials.gov
December 11, 2025	NCT07277998	Alternating Triamcinolone and Platelet-Rich Plasma Therapy for Oral Submucous Fibrosis	Karachi Medical and Dental College	Not applicable	Not yet recruiting	Oral Submucous Fibrosis	40	Pakistan	clinicaltrials.gov
December 8, 2025	NCT07270601	Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis	ContextVision AB	Not applicable	Recruiting	MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, NAFLD - Non-Alcoholic Fatty Liver Disease	110	United States	clinicaltrials.gov
December 5, 2025	NCT07268196	Impact of Liver Transplantation on Sexual Life and Function	Institute of Liver and Biliary Sciences, India	Observational	Recruiting	Chronic Liver Disease and Cirrhosis	100	India	clinicaltrials.gov
December 5, 2025	NCT07267260	Evaluating the Efficacy of Vonoprazan in Preventing Post-Endoscopic Variceal Band Ligation Ulcers: A Randomized Controlled Trial	King Edward Medical University	Phase 2	Recruiting	Cirrhoses, Liver	154	Pakistan	clinicaltrials.gov
November 25, 2025	NCT07249112	DEFINITION OF THE GENOMIC LANDSCAPE OF MASLD	Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico	Not applicable	Completed	Cirrhosis, MASLD	2,880	Italy	clinicaltrials.gov
November 17, 2025	NCT07230964	Correlation Between an Impedance Cardiography Test for Decompensation and the Development of Left Ventricular Replacement Fibrosis	Dermed Diagnostics, Inc.	Not applicable	Recruiting	Aortic Stenosis	6	United States	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
Northern Jiangsu People's Hospital	10	September 10, 2026
Assiut University	4	September 1, 2026
The Second Affiliated Hospital of Chongqing Medical University	4	September 1, 2026
Assistance Publique - Hôpitaux de Paris	4	April 28, 2026
University of Michigan	3	September 15, 2026
Institute of Liver and Biliary Sciences, India	3	July 20, 2026
GlaxoSmithKline	3	July 15, 2026
Hospices Civils de Lyon	3	June 15, 2026
Shanghai Zhongshan Hospital	3	March 16, 2026
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	3	December 15, 2025
Pulmovant, Inc.	2	September 11, 2026
Madrigal Pharmaceuticals, Inc.	2	August 13, 2026
University Hospital Muenster	2	July 14, 2026
General Hospital of Shenyang Military Region	2	June 16, 2026
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla	2	June 16, 2026
Second Affiliated Hospital, Zhejiang University, School of Medicine	2	June 1, 2026
Post Graduate Institute of Medical Education and Research, Chandigarh	2	January 7, 2026
Central Hospital, Nancy, France	2	September 16, 2025
Chinese University of Hong Kong	2	June 29, 2025
M.D. Anderson Cancer Center	2	June 8, 2025

By phase

Phase	New trials	Latest
Observational	72	November 5, 2026
Not applicable	58	October 22, 2026
Phase 2	18	August 13, 2026
Phase 4	10	September 15, 2026
Phase 3	9	September 11, 2026
Phase 1/2	3	June 29, 2025
Phase 1	1	May 22, 2026
Early phase 1	1	May 5, 2026

By country

Country	New trials	Latest
United States	40	October 9, 2026
China	33	September 10, 2026
France	14	October 22, 2026
India	8	October 2, 2026
Spain	8	August 31, 2026
Canada	6	July 1, 2026
Italy	5	June 16, 2026
Turkey (Türkiye)	5	June 16, 2026
United Kingdom	5	June 8, 2026
Pakistan	5	April 27, 2026
Germany	4	July 14, 2026
Egypt	4	April 16, 2026
Belgium	3	October 15, 2026
Hong Kong	3	March 4, 2026
Colombia	2	September 9, 2026
Japan	2	July 15, 2026
Taiwan	2	May 4, 2026
Denmark	2	March 13, 2026
Sweden	2	January 15, 2026
Mexico	2	September 2, 2025
Vietnam	1	November 5, 2026
Romania	1	October 13, 2026
Bangladesh	1	September 2, 2026
Norway	1	August 20, 2026
Austria	1	July 17, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.